StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

How the market prices Integrated BioPharma

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Integrated BioPharma trades at 16.6× its earnings, against a median of 4.6× since 2016 — dearer than 93% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 4.6×, today 16.6×

What Integrated BioPharma keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin1.82%vs 52.9%
Operating margin-6.17%vs -42.9%
EBITDA margin-5.50%vs -30.2%
Pretax margin-5.84%vs -13.0%
Net margin-6.48%vs -39.9%
Free cash flow margin2.04%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-15.0%vs -53.5%
Return on assets-11.3%vs -40.7%
Return on invested capital-14.3%vs -33.0%
Return on capital employed-13.8%vs -38.7%

How hard the assets work

Revenue per dollar of assets1.75vs 0.39
Inventory turns a year4.66vs 2.68
Revenue per employee$327.40Kvs $405.05K
Profit per employee-$21.21Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $4.47M.

Cash and short-term investments$4.47M
EBITDA, trailing twelve months-$2.41M
Free cash flow, trailing twelve months$895.00K

Leverage and liquidity

Current ratio3.00vs 3.30
Quick ratio1.35vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-1.18
No flagManipulation risk

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

INBPS&P 500
PeriodINBPS&P 500DifferenceINBP per yearS&P 500 per year
1 month+11.4%+0.6%+10.8 pts
3 months+12.3%+3.4%+8.9 pts
Year to date-49.3%+13.3%−62.6 pts
1 year-41.9%+16.6%−58.5 pts
3 years-40.0%+86.4%−126.4 pts-15.7%+23.1%
5 years-83.0%+81.9%−164.9 pts-29.9%+12.7%
10 years0.0%+318.9%−318.9 pts0.0%+15.4%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M INBP shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265090.0%6,1571.0
Oct 15, 2026509+12625.0%30,2051.0
Sep 30, 202640.0%42,7951.0
Sep 15, 202640.0%5,5001.0
Aug 31, 20264–12,6171.0
Jul 15, 20261,601-11.1%4,3941.0
Jun 30, 20261,8010.0%13,2741.0
Jun 15, 20261,801-14.3%6,0661.0
May 29, 20262,1010.0%22,3071.0
May 15, 20262,1010.0%14,9291.0
Apr 30, 20262,1010.0%27,4811.0
Apr 15, 20262,1010.0%8,1001.0

Every measure, in full

51 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Aug 19, 2008
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
-0.35%
10.9%
Shares Change (QoQ)
-0.11%
0.57%
Float
9M
49M
Shares Held by Insiders
72.4%
11.2%

MarginsIndustry

Gross Margin
1.82%
52.9%
Operating Margin
-6.17%
-42.9%
Pretax Margin
-5.84%
-13.0%
Profit Margin
-6.48%
-39.9%
EBITDA Margin
-5.50%
-30.2%
FCF Margin
2.04%
-9.41%

Returns on capitalIndustry

Return on Equity (ROE)
-15.0%
-53.5%
Return on Assets (ROA)
-11.3%
-40.7%
Return on Invested Capital (ROIC)
-14.3%
-33.0%
Return on Capital Employed (ROCE)
-13.8%
-38.7%

Financial positionIndustry

Current Ratio
3.00
3.30
Quick Ratio
1.35
2.39
Interest Coverage
-225.42
-6.20

GrowthIndustry

Revenue Growth (YoY)
-19.3%
5.71%
Net Income Growth (YoY)
-451.7%
-31.1%
EPS Growth (YoY)
-400.0%
-25.8%
FCF Growth (YoY)
-52.2%
3.26%
Revenue Growth (3Y CAGR)
-4.69%
2.25%
Revenue Growth (5Y CAGR)
-7.15%
6.41%

EfficiencyIndustry

Asset Turnover
1.75
0.39
Inventory Turnover
4.66
2.68
Revenue Per Employee
$327.40K
$405.05K
Profits Per Employee
-$21.21K
-$704.12K
Employee Count
134
75

Income statement (TTM)Industry

Revenue
$43.87M
$58.79M
Gross Profit
$800.00K
$103.58M
Operating Income
-$2.71M
-$21.49M
Pretax Income
-$2.56M
-$14.83M
Net Income
-$2.84M
-$22.47M
EBITDA
-$2.41M
-$17.14M
EPS (Diluted)
-$0.09
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$4.47M
$15.35M
Net Cash Per Share
$0.14
$0.71
Equity (Book Value)
$17.67M
$49.84M
Book Value Per Share
$0.57
$1.45
Tangible Book Value
$17.67M
$23.91M
Working Capital
$11.58M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
$1.24M
-$12.17M
Capital Expenditures
-$346.00K
-$1.03M
Free Cash Flow
$895.00K
-$20.28M
FCF Per Share
$0.03
-$0.42

Taxes and interestIndustry

Interest Expense
$12.00K
$3.07M
Income Tax
$279.00K
$80.43K

Scores and fair valueIndustry

Piotroski F-Score
4
4
Beneish M-Score
-1.18
-2.62

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?